CURE Quarterly Feature: Calming Chemobrain & Late Effects of Pediatric Cancer

We are pleased to have Kathy LaTour with CURE Magazine back with us for her quarterly feature here on Because Hope Matters Radio. Kathy's latest article in CURE discussed the chemo fog -- dubbed "chemobrain." Until recently, the cognitive impairment experienced by patients post-treatment has been a bit of a mystery. Quality of life, ability to work and family relationships can all be impacted as the muddle becomes apparent, and may include: attention and concentration difficulties, changes in executive functioning and psychomotor ability, diminished processing speed, language and visual-spatial skill problems. Finally, there are therapeutic and practical approaches to help lessen the frustration and provide possible rehabilitation. Kathy will delve into the research outcomes and complexities of chemobrain in this segment.

Furthermore, we'll be talking about the late effects of treatment for adult survivors of pediatric cancers. There are an "estimated 395,000 survivors of childhood cancers living in the U.S. and the vast majority experience treatment fall-out as adults. Health problems range from organ dysfunction to hearing problems to Post Traumatic Stress Disorder (PTSD). Some patients start experiencing "late effects" within six months, for others its years after treatment. Thankfully, there are strides being made to lessen the potential for harm.

Together, we look forward to Kathy LaTour's quarterly visits as she shares the highlights of CURE Magazine as Editor at Large, blended with her compassion and experience as a survivor. Join us for this poignant conversation and wealth of information on Monday, January 27, 2014 at 7:00 PM EST.